AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 100 filers reported holding AVROBIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $650,000 | +12.5% | 650,000 | +333.3% | 0.00% | 0.0% |
Q4 2021 | $578,000 | -54.9% | 150,000 | -34.8% | 0.00% | -66.7% |
Q3 2021 | $1,283,000 | -72.0% | 230,000 | -55.3% | 0.01% | -71.4% |
Q2 2021 | $4,578,000 | -10.1% | 515,000 | +28.4% | 0.02% | -12.5% |
Q1 2021 | $5,091,000 | – | 401,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,236,123 | $21,570,000 | 14.96% |
Aisling Capital Management LP | 1,009,779 | $17,621,000 | 6.72% |
Burrage Capital Management LLC | 225,900 | $3,942,000 | 2.76% |
New Leaf Venture Partners, L.L.C. | 315,550 | $5,506,000 | 1.58% |
TANG CAPITAL MANAGEMENT LLC | 800,000 | $13,960,000 | 1.36% |
Camber Capital Management LP | 1,350,000 | $23,558,000 | 1.35% |
Parkman Healthcare Partners LLC | 190,593 | $3,326,000 | 0.94% |
Eventide Asset Management | 1,905,307 | $33,248,000 | 0.72% |
Penn Mutual Asset Management | 37,306 | $651,000 | 0.66% |
EMERALD ADVISERS, LLC | 832,474 | $14,527,000 | 0.63% |